"Selective" serotonin 5-HT_2A receptor antagonists.

Area of Science:

• Neuroscience
• Pharmacology
• Psychiatry

Background:

• The serotonin 5-HT_2A receptor (5-HT_2AR) is a key target for antipsychotics and psychedelics.
• Current 5-HT_2AR antagonists lack selectivity, hindering mechanistic studies.
• Understanding 5-HT_2AR function is vital for treating major depressive disorder, schizophrenia, and substance use disorders.

Purpose of the Study:

• To review the limitations and strengths of existing selective 5-HT_2AR antagonists.
• To discuss molecular determinants of 5-HT_2AR antagonist selectivity.
• To highlight the role of computational methods in discovering novel, selective 5-HT_2AR antagonists.

Main Methods:

• Review of existing literature on 5-HT_2AR antagonists.
• Analysis of molecular pharmacology data.
• Discussion of computational approaches in drug discovery.

Main Results:

• Current "selective" 5-HT_2AR antagonists have limitations in specificity.
• Molecular determinants influencing antagonist selectivity are complex.
• Computational and molecular pharmacology can guide the development of highly selective antagonists.

Conclusions:

• Achieving unambiguous 5-HT_2AR antagonist selectivity is challenging but essential.
• Novel, selective antagonists are needed for robust mechanistic insights.
• Advanced pharmacological and computational tools are key to future drug development for neuropsychiatric disorders.